123 related articles for article (PubMed ID: 16828908)
1. A versatile phantom for quality assurance in the UK Medical Research Council (MRC) RT01 trial (ISRCTN47772397) in conformal radiotherapy for prostate cancer.
Moore AR; Warrington AP; Aird EG; Bidmead AM; Dearnaley DP
Radiother Oncol; 2006 Jul; 80(1):82-5. PubMed ID: 16828908
[TBL] [Abstract][Full Text] [Related]
2. Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer.
Sydes MR; Stephens RJ; Moore AR; Aird EG; Bidmead AM; Fallowfield LJ; Graham J; Griffiths S; Mayles WP; McGuire A; Stanley S; Warrington AP; Dearnaley DP;
Radiother Oncol; 2004 Aug; 72(2):199-211. PubMed ID: 15297138
[TBL] [Abstract][Full Text] [Related]
3. The evolution of quality assurance for intensity- modulated radiation therapy (IMRT): sequential tomotherapy.
Woo SY; Grant W; McGary JE; Teh BS; Butler EB
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):274-86. PubMed ID: 12694849
[TBL] [Abstract][Full Text] [Related]
4. Prostate dosimetry in an anthropomorphic phantom.
Yu PK; Cheung T; Butson MJ
Australas Phys Eng Sci Med; 2004 Jun; 27(2):60-2. PubMed ID: 15462587
[TBL] [Abstract][Full Text] [Related]
5. Biological consequences of MLC calibration errors in IMRT delivery and QA.
Moiseenko V; Lapointe V; James K; Yin L; Liu M; Pawlicki T
Med Phys; 2012 Apr; 39(4):1917-24. PubMed ID: 22482613
[TBL] [Abstract][Full Text] [Related]
6. CTV to PTV margins for prostate irradiation. Three-dimensional quantitative assessment of interfraction uncertainties using portal imaging and serial CT scans.
Pérez-Romasanta LA; Lozano-Martín E; Velasco-Jiménez J; Mendicote-León F; Sanz-Martín M; Torres-Donaire J; Carrascosa-Fernández C; Zapata-Jimínez JC; Arjona-Gutiérrez J; Gil-Agudo A
Clin Transl Oncol; 2009 Sep; 11(9):615-21. PubMed ID: 19776002
[TBL] [Abstract][Full Text] [Related]
7. On-line quality assurance of rotational radiotherapy treatment delivery by means of a 2D ion chamber array and the Octavius phantom.
Van Esch A; Clermont C; Devillers M; Iori M; Huyskens DP
Med Phys; 2007 Oct; 34(10):3825-37. PubMed ID: 17985628
[TBL] [Abstract][Full Text] [Related]
8. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer.
Yan D; Lockman D; Brabbins D; Tyburski L; Martinez A
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):289-302. PubMed ID: 10925000
[TBL] [Abstract][Full Text] [Related]
9. Application of dose compensation in image-guided radiotherapy of prostate cancer.
Wu Q; Liang J; Yan D
Phys Med Biol; 2006 Mar; 51(6):1405-19. PubMed ID: 16510952
[TBL] [Abstract][Full Text] [Related]
10. Simplified intensity-modulated arc therapy for dose escalated prostate cancer radiotherapy.
Bauman G; Gete E; Chen JZ; Wong E
Med Dosim; 2004; 29(1):18-25. PubMed ID: 15023389
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy treatment planning of prostate cancer using magnetic resonance imaging alone.
Lee YK; Bollet M; Charles-Edwards G; Flower MA; Leach MO; McNair H; Moore E; Rowbottom C; Webb S
Radiother Oncol; 2003 Feb; 66(2):203-16. PubMed ID: 12648793
[TBL] [Abstract][Full Text] [Related]
12. Target volume definition in conformal radiotherapy for prostate cancer: quality assurance in the MRC RT-01 trial.
Seddon B; Bidmead M; Wilson J; Khoo V; Dearnaley D
Radiother Oncol; 2000 Jul; 56(1):73-83. PubMed ID: 10869758
[TBL] [Abstract][Full Text] [Related]
13. A quality assurance phantom for IMRT dose verification.
Ma CM; Jiang SB; Pawlicki T; Chen Y; Li JS; Deng J; Boyer AL
Phys Med Biol; 2003 Mar; 48(5):561-72. PubMed ID: 12696795
[TBL] [Abstract][Full Text] [Related]
14. Commissioning and quality assurance of a commercial stereotactic treatment-planning system for extracranial IMRT.
Wang L; Li J; Paskalev K; Hoban P; Luo W; Chen L; McNeeley S; Price R; Ma C
J Appl Clin Med Phys; 2006; 7(1):21-34. PubMed ID: 16518314
[TBL] [Abstract][Full Text] [Related]
15. MRI-based treatment planning for radiotherapy: dosimetric verification for prostate IMRT.
Chen L; Price RA; Wang L; Li J; Qin L; McNeeley S; Ma CM; Freedman GM; Pollack A
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):636-47. PubMed ID: 15380601
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration.
Parker CC; Damyanovich A; Haycocks T; Haider M; Bayley A; Catton CN
Radiother Oncol; 2003 Feb; 66(2):217-24. PubMed ID: 12648794
[TBL] [Abstract][Full Text] [Related]
17. IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease.
Teh BS; Bastasch MD; Wheeler TM; Mai WY; Frolov A; Uhl BM; Lu HH; Carpenter LS; Chiu JK; McGary J; Woo SY; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):184-91. PubMed ID: 12694837
[TBL] [Abstract][Full Text] [Related]
18. Quality assurance for a treatment planning system in scanned ion beam therapy.
Jäkel O; Hartmann GH; Karger CP; Heeg P; Rassow J
Med Phys; 2000 Jul; 27(7):1588-600. PubMed ID: 10947262
[TBL] [Abstract][Full Text] [Related]
19. Influence of setup errors on spinal cord dose and treatment plan quality for cervical spine tumours: a phantom study for photon IMRT and heavy charged particle radiotherapy.
Karger CP; Schulz-Ertner D; Didinger BH; Debus J; Jäkel O
Phys Med Biol; 2003 Oct; 48(19):3171-89. PubMed ID: 14579859
[TBL] [Abstract][Full Text] [Related]
20. A novel approach to SBRT patient quality assurance using EPID-based real-time transit dosimetry : A step to QA with in vivo EPID dosimetry.
Moustakis C; Ebrahimi Tazehmahalleh F; Elsayad K; Fezeu F; Scobioala S
Strahlenther Onkol; 2020 Feb; 196(2):182-192. PubMed ID: 31925465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
